|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3722 USD | -5.96% |
|
-1.01% | -68.32% |
| 25/06 | BioRestorative Therapies Completes Manufacturing for BRTX-100 Phase 2 Clinical Trial | CI |
| 16/06 | BioRestorative Therapies, Inc.'s Equity Buyback announced on August 12, 2025, has expired. | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 0.479 | 1.2 | 0.5947 |
| Spread/Res. | -22.30% | -68.98% | -37.41% |
| Spread/Supp. | +9.66% | +119.20% | +93.65% |
| Support | 0.3394 | 0.1698 | 0.1922 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BRTX Stock
- Charts BioRestorative Therapies, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
